Development of Magnetic Resonance Imaging - Positron Emission Tomography (MRI-PET) Image Biomarkers for Brain Tumour Grading, Delineation and Measuring Early Treatment Response

Not Applicable

Recruiting

• Conditions: Brain Tumour; Cancer - Brain

• Registration Number: ACTRN12609000877280
• Lead Sponsor: niversity of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-10-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Brain tumour

Exclusion Criteria

Inability to have standard clinical practice MRI or clinical trial FDOPA PET

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Develop new, more sensitive PET and MRI measures for detecting early treatment response.<br>Historical comparisons with data stored on University of Queensland Brain Tumour MRI database (1/5/07 - 1/10/09)[12 months after study entry.]

Secondary Outcome Measures

Name	Time	Method
se advanced MRI methods and PET markers and computer analysis to determine tumour response to treatment.[12 monthe after study entry.]